Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine-derived fungus Aspergillus versicolor

Nat Prod Res. 2018 Mar;32(5):558-563. doi: 10.1080/14786419.2017.1329732. Epub 2017 May 16.

Abstract

A novel anthraquinone, 2-(dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (1), together with nine known compounds (2-10), were isolated from the fermentation of Aspergillus versicolor derived from deep sea sediment. Their structures were established through spectroscopic methods. Compound 1 exhibited strong inhibitory activities against MRSA ATCC 43300 and MRSA CGMCC 1.12409 (with MIC values of 3.9 and 7.8 μg/mL respectively) and moderate activities against tested strains of Vibrio (with MIC values ranging from 15.6 to 62.5 μg/mL). Compound 1 was subjected to molecular docking studies for inhibition of topoisomerase IV and AmpC β-lactamase enzymes indicating its usefulness as antimicrobial agent.

Keywords: Aspergillus versicolor; anthraquinone; antibacterial.

MeSH terms

  • Anthraquinones / chemistry*
  • Anti-Infective Agents / chemistry*
  • Anti-Infective Agents / pharmacology*
  • Aquatic Organisms
  • Aspergillus / chemistry*
  • Bacterial Proteins / antagonists & inhibitors
  • Bacterial Proteins / metabolism
  • DNA Topoisomerase IV / antagonists & inhibitors
  • Drug Evaluation, Preclinical
  • Fermentation
  • Geologic Sediments / microbiology
  • Methicillin-Resistant Staphylococcus aureus / drug effects
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Molecular Structure
  • Topoisomerase Inhibitors / chemistry
  • Topoisomerase Inhibitors / pharmacology
  • Vibrio / drug effects
  • beta-Lactamases / metabolism

Substances

  • Anthraquinones
  • Anti-Infective Agents
  • Bacterial Proteins
  • Topoisomerase Inhibitors
  • AmpC beta-lactamases
  • beta-Lactamases
  • DNA Topoisomerase IV